Pages that link to "Q38763559"
Jump to navigation
Jump to search
The following pages link to Current and emerging therapeutic targets for IBD. (Q38763559):
Displaying 50 items.
- Metabolic Variability of a Multispecies Probiotic Preparation Impacts on the Anti-inflammatory Activity. (Q41159790) (← links)
- The Impact of Western Diet and Nutrients on the Microbiota and Immune Response at Mucosal Interfaces (Q41159836) (← links)
- Reactivation of Intestinal Inflammation Is Suppressed by Catestatin in a Murine Model of Colitis via M1 Macrophages and Not the Gut Microbiota. (Q41487887) (← links)
- AMP-activated protein kinase: a therapeutic target in intestinal diseases. (Q41567299) (← links)
- Anti-NKG2D mAb: A New Treatment for Crohn's Disease? (Q41660377) (← links)
- Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challenges (Q42375646) (← links)
- The Intricate Link among Gut "Immunological Niche," Microbiota, and Xenobiotics in Intestinal Pathology. (Q46763977) (← links)
- Interleukin-25 enhances the capacity of mesenchymal stem cells to induce intestinal epithelial cell regeneration (Q47171983) (← links)
- Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis. (Q47754415) (← links)
- Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis (Q47840447) (← links)
- Editorial: biologics in inflammatory bowel disease-time for direct comparisons (Q48315875) (← links)
- New and emerging therapies for acute and chronic graft versus host disease (Q49238507) (← links)
- Suppression Colitis and Colitis-Associated Colon Cancer by Anti-S100a9 Antibody in Mice (Q49316629) (← links)
- Sentinels at the frontline: the role of intraepithelial lymphocytes in inflammatory bowel disease (Q49834319) (← links)
- Essential immunologic orchestrators of intestinal homeostasis. (Q50027164) (← links)
- Rack1 maintains intestinal homeostasis by protecting the integrity of the epithelial barrier (Q50061426) (← links)
- Current and emerging therapeutic targets for IBD. (Q50091506) (← links)
- A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models (Q52668335) (← links)
- Mesenchymal Stromal Cells and Their Extracellular Vesicles Enhance the Anti-Inflammatory Phenotype of Regulatory Macrophages by Downregulating the Production of Interleukin (IL)-23 and IL-22. (Q52715796) (← links)
- Hydrogen peroxide production by lactobacilli promotes epithelial restitution during colitis. (Q54958013) (← links)
- Editorial: Immune-Epithelial Crosstalk in Inflammatory Bowel Diseases and Mucosal Wound Healing. (Q55260708) (← links)
- Protective Effects of Salvianolic Acid A against Dextran Sodium Sulfate-Induced Acute Colitis in Rats. (Q55478212) (← links)
- The Relationship between Gender, Severity of Disease, Treatment Type, and Employment Outcome in Patients with Inflammatory Bowel Disease in Israel (Q57115319) (← links)
- Using single cell analysis for translational studies in immune mediated diseases: Opportunities and challenges (Q57297087) (← links)
- An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease (Q57943350) (← links)
- Regulation of S100A8 Stability by RNF5 in Intestinal Epithelial Cells Determines Intestinal Inflammation and Severity of Colitis (Q58721652) (← links)
- Retinoic Acid, Leaky Gut, and Autoimmune Diseases (Q58801064) (← links)
- Oral Adjuvant Curcumin Therapy for Attaining Clinical Remission in Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (Q59810580) (← links)
- Modulating T Cell Responses via Autophagy: The Intrinsic Influence Controlling the Function of Both Antigen-Presenting Cells and T Cells (Q60954864) (← links)
- mPGES-1-Mediated Production of PGE and EP4 Receptor Sensing Regulate T Cell Colonic Inflammation (Q60954891) (← links)
- Population Pharmacokinetics of the Interleukin-23 Inhibitor Risankizumab in Subjects with Psoriasis and Crohn's Disease: Analyses of Phase I and II Trials (Q62633603) (← links)
- T lymphocytes in the intestinal mucosa: defense and tolerance (Q64115581) (← links)
- Effects of Roxb. and L. in an In Vitro Intestinal Inflammation Model Using Immune Cells and Caco-2 (Q64460344) (← links)
- Reproducing the human mucosal environment ex vivo: inflammatory bowel disease as a paradigm. (Q64911664) (← links)
- Nanoparticle-Based Oral Drug Delivery Systems Targeting the Colon for Treatment of Ulcerative Colitis. (Q64929129) (← links)
- Restoration of mucosal integrity and epithelial transport function by concomitant anti-TNFα treatment in chronic DSS-induced colitis (Q89396658) (← links)
- Advances in Pharmaceutical Strategies Enhancing the Efficiencies of Oral Colon-Targeted Delivery Systems in Inflammatory Bowel Disease (Q89422232) (← links)
- Glucocorticoids Inhibit Group 3 Innate Lymphocyte IL-22 Production (Q89449439) (← links)
- CD74 Signaling Links Inflammation to Intestinal Epithelial Cell Regeneration and Promotes Mucosal Healing (Q89468999) (← links)
- The JAK inhibitor ruxolitinib reduces inflammation in an ILC3-independent model of innate immune colitis (Q89486269) (← links)
- Homeoprotein OTX1 and OTX2 involvement in rat myenteric neuron adaptation after DNBS-induced colitis (Q89868709) (← links)
- Mechanism-Based Treatment Strategies for IBD: Cytokines, Cell Adhesion Molecules, JAK Inhibitors, Gut Flora, and More (Q90320869) (← links)
- Small molecule oral targeted therapies in ulcerative colitis (Q90323324) (← links)
- The possibility of using shogaol for treatment of ulcerative colitis (Q90325486) (← links)
- Substrate-based kinase activity inference identifies MK2 as driver of colitis (Q90740755) (← links)
- High-dimensional immune phenotyping and transcriptional analyses reveal robust recovery of viable human immune and epithelial cells from frozen gastrointestinal tissue (Q90966970) (← links)
- Interrogating host immunity to predict treatment response in inflammatory bowel disease (Q91452268) (← links)
- Human Intestinal Mononuclear Phagocytes in Health and Inflammatory Bowel Disease (Q91636298) (← links)
- NIK signaling axis regulates dendritic cell function in intestinal immunity and homeostasis (Q91704520) (← links)
- Baseline levels of dynamic CD4 T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study (Q91949578) (← links)